SCHEMBL3976427

SCHEMBL3976427

CCCCOc1cccc(-c2ccoc2C(=O)OC(=O)c2ccc(O)c(C#N)c2C(=O)NN)c1

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
USP2 O75604 1/20 0.38
MAPK1 P28482 1/20 0.38
MEN1 O00255 1/20 0.37
ADRB2 P07550 1/20 0.37
KMT2A Q03164 1/20 0.37
CHRM2 P08172 1/20 0.37
CHRM4 P08173 1/20 0.37
CHRM5 P08912 1/20 0.37
CHRM1 P11229 1/20 0.37
CHRM3 P20309 1/20 0.37
KDM4E B2RXH2 1/20 0.36
ALDH1A1 P00352 1/20 0.36
LMNA P02545 1/20 0.36
GAA P10253 1/20 0.36
HTT P42858 1/20 0.36
SMN1; SMN2 Q16637 1/20 0.36
NR1H4 Q96RI1 2/20 0.35
PTPN11 Q06124 1/20 0.35
MCL1 Q07820 1/20 0.35
ADORA1 P30542 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3975741 0.90 NR1H4 (0.38) MAPK1KDM4EALDH1A1LMNAGAA
SCHEMBL3977732 0.87 GUSB (0.39) MAPK1KDM4EALDH1A1GAAHTT
SCHEMBL3973253 0.87 MEN1 (0.36) MEN1KMT2AKDM4EALDH1A1SMN1; SMN2
SCHEMBL3979343 0.87 SPHK2 (0.36) MAPK1KDM4EMCL1
SCHEMBL3976994 0.86 ALOX15 (0.31) MAPK1ALDH1A1GAA
SCHEMBL3976897 0.86 GCGR (0.40) USP2MAPK1MEN1ADRB2KMT2A
SCHEMBL3976065 0.85 GPR132 (0.37) MAPK1LMNAADORA1SMPD1CYP11B1
SCHEMBL3977150 0.85 KISS1R (0.38) MCL1ADORA1
SCHEMBL3976175 0.85 FABP1 (0.31) MEN1KMT2A
SCHEMBL3976483 0.84 MAPK8 (0.39) MAPK1MCL1SMPD1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7514452-B2 2-furancarboxylic acid hydrazides and pharmaceutical compositions containing the same DAINIPPON PHARMACEUTICAL CO., LTD (JP) 2009-04-07 US disclosed
US-20050171196-A1 2-Furancarboxylic acid hydrazides and pharmaceutical compositions containing the same DAINIPPON SUMITOMO PHARMA CO., LTD. (JP) 2005-08-04 US disclosed
EP-1489077-A1 2-FURANCARBOXYLIC ACID HYDRAZIDES AND PHARMACEUTICAL COMPOSITIONS CONTAINING THE SAME DAINIPPON PHARMACEUTICAL CO., LTD. (JP) 2004-12-22 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050171196-A1 2-Furancarboxylic acid hydrazides and pharmaceutical compositions containing the same GLP1R, GCGR, GPR119 USP2 2592/4885MAPK1 2656/4885MEN1 1481/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.